Van Vliet David A 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Apr 29, 2009
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
Van Vliet David A
Interim Pres./ Interim CEO, KV
Transactions
- Award
Option to Purchase
2009-04-24+50,000→ 50,000 totalExercise: $1.52Exp: 2019-04-24→ Class A Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in two installments: 50% on December 31, 2009 and 50% on December 31, 2010.